Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
11 drugs for “B-cell Lymphoma”
Approved 4
- Loncastuximab tesirineADC Therapeutics SARefractory Diffuse Large B-Cell Lymphoma; Relapsed Diffuse Large B-Cell Lymphoma
- SonrotoclaxBeOne Medicines Ltd.B Cell Lymphoma
- UblituximabTG THERAPEUTICS, INC.Diffuse Large B-Cell Lymphoma
- ZanubrutinibBeOne Medicines Ltd.B Cell Lymphoma
Phase 3 7
- AZD0486ASTRAZENECA PLCLarge B-cell Lymphoma
- CTL019NOVARTIS AGDiffuse Large B-cell Lymphoma
- HMPL-760HUTCHMED (China) LtdRelapsed/Refractory Diffuse Large B-Cell Lymphoma
- NX-5948Nurix Therapeutics, Inc.B-cell Lymphoma
- OdronextamabREGENERON PHARMACEUTICALS, INC.Diffuse Large B-cell Lymphoma (DLBCL)
- Rondecabtagene autoleucelLyell Immunopharma, Inc.Diffuse Large B Cell Lymphoma (DLBCL); Diffuse Large B Cell Lymphoma Refractory; Diffuse Large B Cell Lymphoma Relapsed
- Zilovertamab vedotinMerck & Co., Inc.Diffuse Large B-Cell Lymphoma
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.